Introduction {#sec1-1}
============

Skeletal muscle fibres are classified accor ding to their contractile and metabolic properties. The contractile properties depend on the composition in myosin heavy chain isoform (MyHC) (for a review see Schiaffino and Reggiani).^[@ref1]^ MyHC encoded by a multigene family^[@ref2]^ is the major component of the contractile apparatus combining with actin to form the actomyosin complex which is responsible for the elastic and contractile properties of muscle. Evolution in the knowledge about MyHC isoforms led to progression in the classification of fibres using different techniques.^[@ref3]^ Firstly, the histochemical technique was based on the revelation of the ATPase activity of MyHC and allowed to distinguish between slow and fast muscle fibres. The myosin ATPase activity is higher in fast than in slow muscles and correlates with muscle shortening speed.^[@ref4]^ Then, the combination of different pH of preincubation for the revelation of ATPase activity revealed three types of fibres mainly I, IIA and IIB.^[@ref5],[@ref6]^ The discovery of the activity of oxidative enzymes *(e.g.,* the Succinate dehydrogenase, SDH) helped distinguish oxidative and non oxidative fibres.^[@ref7]^ A combination of methods to simultaneously detect contractile and metabolic properties can detect slow-oxidative fibres, fast glycolytic and fast oxidative fibres.^[@ref3]^ Then, with the progress of immunology, anti MyHC monoclonal antibodies were produced. Their use by immunohisto-chemistry on serial sections enabled the detection of four types of fibres in rat, mouse, rabbit, pig muscles: I, IIA, IIX (or IID) and IIB.^[@ref8]^ The development of electrophoretic separation of MyHC according to their molecular weights also revealed the existence of four MyHC in adult rodent muscles.^[@ref9]^ Moreover, the use of monoclonal antibodies demonstrated that some fibres called hybrid fibres contain several isoforms of MyHC. *In situ* hybridization analysis on single fibre, confirmed that rodent muscles contain a spectrum of fibre types, including hybrid fibres with preferential combinations of MYH transcripts, according to the following sequence: I⇆I / IIA ⇆ IIA ⇆ IIA/ IIX ⇆ IIX ⇆ IIX/ IIB ⇆ IIB.^[@ref10]^

Among the different techniques, immuno-histochemistry is the most accurate as it makes it possible to distinguish pure and hybrid fibres. This method has been used for the analysis of skeletal muscle in different species;^[@ref3],[@ref11],[@ref12]^ for the studies in mice, different antibodies are available.^[@ref13],[@ref14]^ Several hundred of fibres might reasonably be analyzed per biological sample by comparing serial sections using different anti MyHC antibodies. The manual analysis of the different sections is laborious and time consuming, that is why several authors developed semi-automatic image analysis softwares.^[@ref15],[@ref16]^

The aim of the present study was to adapt the method of Meunier *et al.* for the classification of contractile fibre types in mouse.^[@ref16]^ Our objective was to use a minimum number of antibodies to reduce the number of serial sections to be compared. We first tested a combination of several anti MyHC antibodies. Then, we validated the classification of the fibres obtained by immunohistochemistry through a comparison with the MyHC electrophoretic pattern on the same samples.

Materials and Methods {#sec1-2}
=====================

Animals and experimental procedure {#sec2-1}
----------------------------------

Two muscles known to have a different composition of fibre types were studied, namely the m. *Soleus* (SOL) and m. *Tibialis Anterior* (TA)*.* According to the literature, the SOL is a slow oxidative muscle and the TA a fast glycolytic muscle.^[@ref17],[@ref18]^ Both muscles were dissected from anaesthetized male C57BL6 mice at 12 weeks of age (n=8). Following dissection, they were frozen in liquid nitrogen and stored at - 80°C for further analysis.

Immunohistochemical detection of myosin heavy chains {#sec2-2}
----------------------------------------------------

### MyHC antibodies {#sec3-1}

For contractile fibre type determination, in order to detect slow and fast MyHC isoforms, we chose anti MyHC antibodies according to the data available for mouse skeletal muscle ([Table 1](#table001){ref-type="table"}). Six antibodies were tested on serial sections. BA-D5 specific for MyHC I, SC71 specific for MyHC IIa, BF-F3 specific for MyHC IIb,^[@ref19]^ S5-8H2 for MyHC I, IIx and IIb. These antibodies were purchased from AGRO-BIO (La Ferté Saint Aubin, France).^[@ref20]^ N2.261, which reveals MyHC I and IIa, and RTD-9 labelling MyHC IIx^[@ref19]^ were purchased from Enzo Life Sciences (ELS) (Lyon, France). The reactivity of these antibodies has been validated on mouse muscles.^[@ref17]^

### Immunohistochemical revelation {#sec3-2}

Serial transverse sections (10-µm thick) were obtained from each muscle sample using a cryostat (Cryo-star HM 560, Microm International GmbH, Germany) at -26°C, mounted on glass slides and stained using immunohistochemical methods. The sections were blocked to eliminate non specific binding in 5% BSA diluted in phosphate-buffered saline (PBS) for 10 min. The cross-sections were then incubated with primary antibodies in a humidified chamber for one hour in the dark at 37°C (dilution conditions illustrated in [Table 2](#table002){ref-type="table"}). After washing in phosphate-buffered saline, the sections were then incubated with the secondary antibodies for 30 min in the dark at 37°C.^[@ref16]^ Each anti MyHC antibody was used double labelling with anti laminin antibody on the same section. The MyHC isoforms were revealed by an Alexa Fluor 488 labeled goat anti-mouse IgG secondary antibody (A11001, Invitrogen, Carlsbad, CA, USA, dilution 1/200). For BF-F3, we used an Alexa Fluor 546 anti-mouse IgM secondary antibody (A11010, Invitrogen ; dilution 1/1000). The cell outline was stained using a rabbit anti-laminin primary polyclonal antibody (L9393 Sigma-Aldrich, St. Louis, MO, USA; [Table 2](#table002){ref-type="table"}) and a goat anti-rabbit IgG Cy3-labeled secondary antibody (111-165-008, Jackson Immunoresearch Labs, West Grove, PA, USA, dilution 1/200). After further washing in PBS, sections were mounted with cover slips using Fluoromount (F4680, Sigma-Aldrich). Finally, negative control experiments (section incubated without specific primary antibodies and anti-laminin antibody) were performed with all immunohisto-chemical staining to demonstrate the non-specific reactivity.

### Image acquisition and analysis {#sec3-3}

Histological sections were visualized under an Olympus fluorescence microscope BX 51, using a 10X objective (NA=0.3) and adequate band pass filter (Alexa 488: excitation filter 460-495, emission filter 510-550, dichromatic mirror 505LP; Cy3: excitation filter 530-550, emission filter 575-625, dichromatic mirror 565LP) as described by Meunier *et al.*^[@ref16]^ High resolution grayscale images were acquired with an Olympus cooled digital camera DP-72 with cell-F software (Olympus Soft Imaging Solutions, Münster, Germany). For each field of each serial section, two images corresponding to the laminin and MyHCs labelling respectively were digitized. Image processing and image analysis were realized with the *FibTypFluo* program developed in visual basic under the Visilog 6.9 Professional Software (Noesis, Gif-sur-Yvette, France).

This program is described in a flow chart^[@ref16]^ and permits to automatically determine the muscle fibre type proportion (%), mean cross-sectional area (CSA) per type and fibre density (number per mm^2^) for an average 300 fibres per serial image.

### Electrophoretic separation of MyHC isoforms {#sec3-4}

Muscle proteins were extracted with a buffer containing 0.5 M NaCl, 20 mM NaPPi, 50 mM Tris, 1 mM EDTA and 1 mM DTT according to the protocol described by Picard *et al.*^[@ref21]^ Samples were homogenized with a polytron. Following centrifugation at 2500 x g for 10 min at 4°C, the supernatants were diluted 1:1 (v/w) with glycerol and stored at -20°C. The protein concentration of the samples was determined according to the method of Bradford.^[@ref22]^

The samples were suspended in 1:1 v/v in a basic 2 x Laemmli solution containing 4% w/v sds, 10% v/v β-mercaptoethanol, 20% v/v glycerol, 125 mM Tris (pH 6.8) and 0.01 % w/v pyronin Y, incubated at room temperature for 10 min and then heated (70°C) for 10 min. The MyHC isoforms were separated with SDS glycerol gel electrophoresis on 160 x 160 x 1.5 mm plates using a Hoefer system in accordance with the method of Laemmli.^[@ref23]^ The stacking gel contained 4% polyacrylamide with a cross-link of 1.96 %. The separating gel was an 8 % polyacrylamide gradient with a cross-link of 1%, as described in Mizunoya *et al.^[@ref24]^* A critical factor affecting the resolution of MyHC isoforms was the addition of glycerol to the gel matrix with a final concentration of 35%, according to Sugiura *et al.*^[@ref25]^) Three micrograms of protein were loaded per well onto 0.75-mm-thick gels. The electrophoresis was run at a constant voltage of 140V for 15 h at 4°C. After migration, the gels were stained in a solution of Coomassie Blue. Gel images were captured using the Expression 10000XL Pro scanner (Epson) and the percentages of abundance of each MyHC (I, IIa, IIx and IIb) were quantified using ImageQuant TL v7.0 software (GE Healthcare, Fairfield, CT, USA).

Statistical analysis {#sec2-3}
--------------------

Muscle fibre type distribution and cross-sectional areas were expressed as means and standard deviation. Statistical significance of the differences between means for the different combinations of antibodies was assessed by analysis of variance (ANOVA) using the GLM procedure of SAS Software (Statistical Analysis System, Cary, NC, USA). A Student's *t-*test was performed to compare the fibre type distributions obtained with the immunohistochemical method to those obtained with the electrophoresis method. A probability of less than 5% was considered statistically significant.

Results {#sec1-3}
=======

Choice of the anti MyHC antibodies {#sec2-4}
----------------------------------

Our first aim was to choose the combination of a minimum number of antibodies to obtain a simple and correct typing result while minimizing cost and time. The choice of antibodies was made from the data available in the literature on antibody specificities for mouse skeletal muscles. Among all possible combinations (5 antibodies=23 combinations of two or more antibodies), only those potentially interesting according to the literature were tested according to the muscle studied on one individual.

### Soleus muscle {#sec3-5}

Several authors demonstrated at protein^[@ref26]^ or transcript level,^[@ref17]^ that SOL did not contain IIb MyHC. We therefore used the BF-F3 antibody which specifically recognizes IIB fibres in mouse,^[@ref27]^ on eight SOL samples and confirmed the absence of MyHC IIb isoform in the SOL ([Figure 1](#fig001){ref-type="fig"}). Then, four combinations of antibodies were tested on one mouse and compared to the BA-D5/SC71/S5-8H2 combination used as a reference. As observed in [Table 3](#table003){ref-type="table"}, all the combinations revealed equivalent proportions of MyHC in the SOL, with a low coefficient of variation between the different combinations tested. Among the 4 combinations tested, the BA-D5/SC71 was preferred due to the specificity of these antibodies to recognize a single fibre type ([Table 1](#table001){ref-type="table"}) facilitating image analysis.

### Tibialis Anterior muscle {#sec3-6}

In the literature, this muscle is said not to contain slow type I fibres. We verified it in the eight samples by using the BA-D5 antibody that is specific for slow MyHC. With this antibody we did not observe any labelling which confirms the absence of type I fibres in the TA ([Figure 2](#fig002){ref-type="fig"}). As for the SOL, we tested six different combinations of antibodies ([Table 4](#table004){ref-type="table"}). All the combinations revealed nearly the same proportions of fibres in the TA. Among the combinations tested, the BF-F3/SC71 combination was chosen because it enables efficient typing of fibres. The pattern of SC71 staining intensities revealed the existence of unlabelled, labelled and intermediary labelled fibres ([Figure 2](#fig002){ref-type="fig"}). The intermediary labelled fibres contained less abundance of IIa MyHC than marked fibres, they were IIA-X hybrid fibres. Lastly, no hybrid IIX-B fibres were detected. This was confirmed by using RTD9 as control for MyHC IIx labelling (*data not shown*).

Characterisation of fibres by image analysis {#sec2-5}
--------------------------------------------

Fibre type composition was determined in 8 mice with the two selected combinations of antibodies using semi-automatic image analysis as described by Meunier *et al.*^[@ref16]^ The mean percentages of each fibre type were in agreement with the data presented in [Tables 3](#table003){ref-type="table"} and [4](#table004){ref-type="table"}, and with data from the literature.

In the TA, we revealed a predominance of type IIB (57%). A low percentage of hybrid IIAX fibres (3%) was observed ([Table 5](#table005){ref-type="table"}). No hybrid IIX/IIB fibres were observed. This result was confirmed using anti RTD9 antibody (*data not shown*). The SOL consisted mainly of type IIA and I fibres (respectively 46% and 43%, [Table 5](#table005){ref-type="table"}). We did not observe any hybrid fibres in this muscle. We estimated the total number of fibres on the whole muscle section area in both SOL (muscle area 2 mm^[@ref2]^) and TA (muscle area \<12 mm^[@ref2]^) muscles ([Figure 3](#fig003){ref-type="fig"}). In the TA*,* 1323 fibres on average (all types combined) were counted *i.e.*, approximately 110 fibres per mm^[@ref2]^. The SOL was composed of 724 fibres and had a higher density of fibres than the TA (511 fibres per mm^[@ref2]^ on average). In the TA muscle, the IIB fibres had significantly the largest CSA and the IIA the lowest ([Table 6](#table006){ref-type="table"}). In the SOL, types I and IIX fibres had significantly the largest area compared to the IIA fibres.

Relationships between immunohis-tochemical classification of fibres and electrophoretic separation of MyHCs isoforms {#sec2-6}
--------------------------------------------------------------------------------------------------------------------

In order to validate our classification we compared the immunohistochemical data with the proportion of each MyHC determined by electrophoresis for both muscles. We separated the four MyHC isoforms: fast (IIa, IIx, IIb) and slow (I) isoforms ([Figure 4](#fig004){ref-type="fig"}). The relative abundances of the MyHC isoforms separated by electrophoresis ([Table 5](#table005){ref-type="table"}) was compared to the classification of fibres obtained with the immunohistochemical technique for both muscles ([Figure 5 A](#fig005){ref-type="fig"},[B](#fig005){ref-type="fig"}). They showed not significant differences. Electrophoresis detected the presence of MyHC IIb in the SOL which was not revealed by immunohistochemistry.

Discussion {#sec1-4}
==========

Our objective was to simplify the semi-automatic classification of muscle fibres of Meunier *et al.,*^[@ref16]^ by using a minimum number of antibodies. As the number of cross sections to compare will be reduced this would simplify the analysis. Moreover the cost of the histological technique would be minimized and it would save analysis time. We show that the use of only two antibodies for each muscle gives the same results than the use of several antibodies. Moreover the proportions of fibres classified with this method have been validated by the electrophoretic separation.

The proportions of the fibre types in the SOL are in agreement with immunohistochemical data from the literature for this muscle in mouse.^[@ref26]^ Agbulut *et al.*^[@ref17]^ showed that the SOL of mouse contained two fast MyHC isoforms (IIa and IIx, 32.2% and 15.2% respectively) and MyHC I (53.6%) as a slow isoform 12 weeks after birth. These authors concluded that in adult mouse, the SOL did not contain IIb MyHC. Moreover, RT-PCR analysis showed that the IIB MyHC transcript was totally absent in the adult SOL. However in our study, the electrophoretic separation of MyHCs allowed the detection of 3% of IIb isoform in accordance with Bloemberg and Quadrilatero.^[@ref28]^ The IIb isoform detected by electrophoresis could probably be present only in hybrid IIX-B fibres containing high proportion of MyHC IIx and very low of MyHC IIb. This could explain why they are not detected by using the BF-F3 antibody in immunohistochemistry. Some studies have showed that the TA muscle of C57BL6J mouse had predominantly IIB fibres and less abundantly IIA-X, IIX, and IIA fibres.^[@ref18],[@ref25],[@ref26]^ Zardini and Parry^[@ref29]^ also concluded that approximately 1/3 of the fibres in the TA of C57BL6J mouse were IIX type. Our classification is therefore in coherence with these data. One of the advantages of working on the mouse muscles is the possibility to have a section of the whole muscle. This is very interesting to determine the exact total number of fibres per muscle and provides a complete characterization of fibre composition. We show that it is possible for both the SOL and TA at 12 weeks of age. The image analysis allowed to evaluate the cross sectional area of each fibre type. In the SOL we showed that high oxidative fibres (type I) were not the smallest. Their cross sectional areas were similar to that of IIX fibres. In the TA the largest were the IIB fibres. These differences in CSA between the different types of fibres in SOL and TA are in accordance with the data of Bloemberg and Quadrilatero.^[@ref28]^

All these data give us confidence to validate the use of the two combinations of antibodies proposed for each muscle. Limitations of this classification could be that IIX fibres are classified only on the basis of the absence of labeling. Moreover, in some specific physiological or pathological conditions hybrid IIX-B fibres could be present. Our classification allowed the observation of these hybrid fibres only by differences in labeling intensities with the different antibodies, which may be criticizable. Consequently, for a more accurate analysis we propose to first systematically use the four antibodies BA-D5/SC71/BF-F3/RTD-9 for the two muscles, as illustrated in [Figure 6](#fig006){ref-type="fig"}. In SOL the BF-F3 antibody should be used only to validate the absence of IIB fibres. In the TA the BA-D5 should be used to validate the absence of type I fibres. If these absences are validated the image-analysis could be based on the combinations of the two antibodies as proposed in this article. If these absences are not validated the image-analysis should be based on the analysis of the three serial sections stained with the three antibodies (BA-D5/SC71/BF-F3). Moreover, for the two muscles the labeling with RTD-9 antibody could be used to validate the IIX or IIX-B fibres.

In conclusion, we propose a simple, fast method of characterization of muscle fibre types and CSA evaluation based on only two anti MyHC antibodies BA-D5/SC71 and BF-F3/SC71 in the m. *Soleus* and the m. *Tibialis Anterior* respectively. The classification of fibres obtained has been validated by comparison with the literature and with the classification realised by the electrophoretic separation of MyHC in the same samples. The choice of anti MyHC antibodies used for the classification should be adapted for each muscle and each physiological or pathological condition studied. The advantage in mouse is that this immunohistochemical classification can be applied to the total area for muscles with small section areas. This means having information on the total number of fibres, their cross-sectional areas and their composition in absolute value rather than in proportions as in other species. Consequently this method can be applied for studies in which phenotyping of skeletal muscle is necessary, such as in mouse knock-out models.
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![Serial sections of m. *Soleus*, stained with antibodies specific to MyHC I (BA-D5), MyHC IIb (BF-F3) and MyHC IIa (SC71). Scale bar: 200 µm.](ejh-2014-2-2254-g001){#fig001}

![Serial sections of m. *Tibialis Anterior* stained with antibodies specific to MyHC I (BA-D5), MyHC IIb (BF-F3) and MyHC IIa (SC71). Scale bar: 200 µm.](ejh-2014-2-2254-g002){#fig002}

![Laminin staining of a) m. *Tibialis Anterior*, and b) m. *Soleus* to determine the number of fibres per muscle. Scale bar: 200 µm.](ejh-2014-2-2254-g003){#fig003}

![Electrophoretic separation of MyHC in a) m. *Soleus*, and b) m. *Tibialis Anterior*. The different wells correspond to different animals. A sample of rat *Gastrocnemius* with the four types of MyHC was used as a control.^[@ref9]^](ejh-2014-2-2254-g004){#fig004}

![Proportions of the different MyHC isoforms (I, IIa, IIx) detected in A) m. *Soleus*, and B) m. *Tibialis Anterior*, with either the histological method or the electrophoretic technique. NS, not significant.](ejh-2014-2-2254-g005){#fig005}

![Strategic scheme of choice of the antibodies combinations to be used for each new experiment. It should be adapted for each muscle and each condition. The four antibodies BA-D5, SC71, BF-F3, RTD-9 should be systematically applied with laminin on serial sections. The first step is to choose the combination of antibodies for image analysis. In absence of MyHC IIb, (BF-F3 negative fibres), the BA-D5/SC71 combination should be used to discriminate type I, IIA, IIX and hybrid fibres. In absence of MyHC I (BA-D5 negative fibres), the SC71/BF-F3 combination should be used to discriminate type IIA, IIX, IIB and hybrid fibres. If these absences are not validated by the image-analysis, the combination BA-D5/SC71/BF-F3 should be used for fibre typing. Labeling with RTD-9 antibody is used only to validate the presence of MyHC IIx in IIX fibres identified by the absence of any labeling.](ejh-2014-2-2254-g006){#fig006}

###### 

Summary of the responses of different anti Myosin Heavy Chains (MyHC) antibodies in mouse *Soleus* and *Tibialis Anterior* muscles.

  Isoforms   MyHC-I   MyHC-IIa   MyHC-IIx   MyHC-IIb
  ---------- -------- ---------- ---------- ----------
  BA-D5      \+       −          −          −
  SC-71      −        \+         −          −
  N2.261     +/-      \+         −          −
  S5-8H2     \+       −          \+         \+
  BF-F3      −        −          −          \+
  RTD-9      −        −          \+         −

According to Duris *et al*.^[@ref11]^, and Schiaffino *et al*.^[@ref27]^; -, unlabeled; +/-, intermediate; +, labeled.

###### 

Conditions for each primary antibody used in this study.

  Antibody                        Dilution
  ------------------------------- ----------
  Monoclonal anti-bovine BA-D5    Pure
  Monoclonal anti-bovine BF-F3    Pure
  Monoclonal anti-bovine S5-8H2   1/2
  Monoclonal anti-bovine SC71     Pure
  Monoclonal anti-human N2.261    1/50
  Monoclonal anti-bovine RTD-9    Pure
  Polyclonal anti-human Laminin   1/200

###### 

Proportions of I, IIA, IIX, and IIB fibres detected with different combinations of antibodies in the m. *Soleus*.

  Fibres types          \% I   \% IIA   \% IIX   \% IIB
  --------------------- ------ -------- -------- --------
  BA-D5/N2.261          37     54       9        0
  BA-D5/S5-8H2          40     50       10       0
  N2.261/S5-8H2         36     56       8        0
  BA-D5/SC71            38     53       9        0
  *BA-D5/SC71/S5-8H2*   *40*   *51*     *9*      *0*
  Mean                  38     53       9        0
  CV(%)                 4      4        8        0

CV, coefficient of variation among serial cross sections; the reference combination is in italics.

###### 

Proportions of I, IIA, IIA-X, IIX, and IIB fibres detected with different combinations of antibodies in the m. *Tibialis Anterior*.

  Fibres types          \% I   \% IIA   \% IIA-X   \% IIX   \% IIB
  --------------------- ------ -------- ---------- -------- --------
  BF-F3/S5-8H2          0      4        5          35       56
  BF-F3/SC71            0      5        4          34       57
  BF-F3/N2.261          0      5        4          33       58
  S5-8H2/N2.261         0      6        5          32       56
  S5-8H2/SC71           0      6        6          32       56
  *BF-F3/SC71/S5-8H2*   *0*    *5*      *4*        *34*     *57*
  Mean                  0      5        5          33       57
  CV (%)                0      19       15         3        2

CV, coefficient of variation among serial cross sections; the reference combination is in italics.

###### 

Muscle fibre type proportions in the m. *Soleus* and m. *Tibialis Anterior* of C57BL6J mouse as detected by immunohistochemical and electrophoretic methods.

                            I    IIA   IIX   IIB
  ------------------------- ---- ----- ----- -----
  m\. *Soleus*                               
    Immunohistochemistry    43   46    11    0
    Electrophoresis         42   44    12    3
  m\. *Tibialis Anterior*                    
    Immunohistochemistry    0    6     34    57
    Electrophoresis         0    7     29    63

The BA-D5/SC71 (m. *Soleus*) and the BF-F3/SC71 (m. *Tibialis Anterior*) combinations were used (n=8 mice). The MyHC isoforms were separated by electrophoresis according to Mizunoya *et al.*^[@ref24]^ Immunohistochemical data are expressed as percent of fibre type proportion; electrophoresis data are expressed as percent abundance of each MyHC.

###### 

Muscle fibre transversal cross-sectional areas in the m. *Soleus* and m. *Tibialis Anterior* of C57BL6J mouse.

  Muscle                     Fibre type                                                                                                                                                    
  -------------------------- ----------------------------------------------- ---------------------------------------------- -------------- ----------------------------------------------- -----------------------------------------------
  CSA (µm^[@ref2]^) (SD)                                                                                                                                                                   
    *m. Soleus*              1187 (308)[^a^](#tfn001){ref-type="table-fn"}   992 (284)[^a^](#tfn001){ref-type="table-fn"}   0 (0)          1116 (390)[^a^](#tfn001){ref-type="table-fn"}   0
    m. *Tibialis anterior*   0 (0)                                           768 (156)^c^                                   919 (190)^c^   1343 (265)[^b^](#tfn001){ref-type="table-fn"}   2268 (436)[^a^](#tfn001){ref-type="table-fn"}

CSA, cross-sectional areas; SD, standard deviation; n=8 mice.

^a,b^Means with the same letter are not significantly different.
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